第一单位：
Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, United Kingdom. Electronic address: gill.barnett@addenbrookes.nhs.uk.
作者：
Gillian C,Barnett [1]
;
Sarah L,Kerns [2]
;
Leila,Dorling [3]
;
Laura,Fachal [4]
;
Miguel E,Aguado-Barrera [5]
;
Laura,Martínez-Calvo [5]
;
Harkeran K,Jandu [6]
;
Ceilidh,Welsh [7]
;
Jonathan,Tyrer [3]
;
Charlotte E,Coles [8]
;
Joanne S,Haviland [9]
;
Christopher,Parker [10]
;
Antonio,Gómez-Caamaño [11]
;
Patricia,Calvo-Crespo [11]
;
Paloma,Sosa-Fajardo [11]
;
Neil G,Burnet [12]
;
Holly,Summersgill [13]
;
Adam,Webb [6]
;
Dirk,De Ruysscher [14]
;
Petra,Seibold [15]
;
Jenny,Chang-Claude [16]
;
Christopher J,Talbot [6]
;
Tim,Rattay [17]
;
Matthew,Parliament [18]
;
Kim,De Ruyck [19]
;
Barry S,Rosenstein [20]
;
Paul D P,Pharoah [3]
;
Alison M,Dunning [3]
;
Ana,Vega [21]
;
Catharine M L,West [13]
;
RGC and REQUITE Consortia
作者单位：
Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, United Kingdom. Electronic address: gill.barnett@addenbrookes.nhs.uk.
[1]
Department of Radiation Oncology, University of Rochester Medical Center, Rochester, New York.
[2]
Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
[3]
Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.
[4]
Fundación Pública Galega de Medicina Xenómica (FPGMX)-SERGAS, Santiago de Compostela, A Coruña, Spain; Grupo Genética en Cáncer y Enfermedades Raras, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, A Coruña, Spain.
[5]
Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom.
[6]
Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
[7]
Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, United Kingdom.
[8]
Clinical Trials and Statistics Unit, Institute of Cancer Research, London, United Kingdom.
[9]
Institute of Cancer Research & Royal Marsden NHS Foundation Trust, London, United Kingdom.
[10]
Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago de Compostela, Spain.
[11]
Proton Beam Therapy Centre, Christie NHS Foundation Trust, Manchester, United Kingdom.
[12]
Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie NHS Foundation Trust, Manchester, United Kingdom.
[13]
Department of Radiation Oncology (Maastro Clinic), Maastricht University Medical Center, GROW School for Oncology and Developmental Biology, Maastricht, The Netherlands; Radiation Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
[14]
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[15]
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Germany.
[16]
Leicester Cancer Research Centre, University of Leicester, Leicester, United Kingdom.
[17]
Division of Radiation Oncology, Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Canada.
[18]
Departments of Basic Medical Sciences and Radiotherapy, Ghent University Hospital, Ghent, Belgium.
[19]
Departments of Radiation Oncology and Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
[20]
Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom; Fundación Pública Galega de Medicina Xenómica (FPGMX)-SERGAS, Santiago de Compostela, A Coruña, Spain; Biomedical Network on Rare Diseases (CIBERER), Spain.
[21]
DOI
10.1016/j.ijrobp.2022.06.098
PMID
35840111
发布时间
2025-05-30
换一批
